Macrophage p47phox regulates pressure overload-induced left ventricular remodeling by modulating IL-4/STAT6/PPARγ

Sukka Santosh Reddy1, Heena Agarwal1, Anant Jaiswal2

  • 1Pharmacology Division, CSIR-Central Drug Research Institute, Lucknow, 226031, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.

Insights

Macrophage p47phox deficiency worsens hypertensive cardiac remodeling by promoting M2 macrophage polarization and fibrosis. This highlights p47phox as a potential therapeutic target for heart disease.

Area of Science:

  • Cardiovascular Research
  • Immunology
  • Molecular Biology

Background:

  • NADPH oxidase (Nox) produces reactive oxygen species (ROS) and influences cardiac remodeling.
  • The specific role of macrophage p47phox, a Nox subunit, in cardiac remodeling under hypertension is not well understood.

Purpose of the Study:

  • To investigate the function of macrophage p47phox in the context of Angiotensin II-induced hypertensive cardiac remodeling.

Main Methods:

  • Utilized p47phox deficient (KO) and wild-type (WT) mice subjected to Angiotensin II infusion or transverse aortic constriction.
  • Performed echocardiography, histology, gene expression analysis, and bone marrow transplantation.
  • Investigated macrophage polarization and signaling pathways (IL-4/STAT6/PPARγ, SOCS3).

Main Results:

  • p47phox KO mice exhibited exacerbated cardiac dysfunction, hypertrophy, and interstitial fibrosis compared to WT mice.
  • KO mice showed increased leukocyte infiltration, CD206+ macrophages, and M2 macrophage markers (Ym1, Arg-1).
  • Macrophage-specific p47phox deficiency aggravated cardiac remodeling, linked to hyperactivated IL-4/STAT6/PPARγ signaling and reduced SOCS3.

Conclusions:

  • Macrophage p47phox plays a protective role by limiting anti-inflammatory signaling and extracellular matrix remodeling during pressure overload.
  • Targeting macrophage p47phox may offer a novel therapeutic strategy for hypertensive cardiac remodeling.